The U.S. Ketamine Clinic industry is growing fast.
This is because more people are looking for new ways to treat mental health problems. It’s already a $3.1B industry, but it’s expected to more than double over the next five years.
Read morePSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
The U.S. Ketamine Clinic industry is growing fast.
This is because more people are looking for new ways to treat mental health problems. It’s already a $3.1B industry, but it’s expected to more than double over the next five years.
Read moreA striking 1,250% increase in internet searches related to microdosing has been observed, reflecting a burgeoning curiosity and acceptance.
Read moreRecent survey results now suggest that psychedelics like LSD, MDMA, and psilocybin may also have protective effects on the brain, potentially countering some aspects of aging.
Read moreThis finding opens new avenues for understanding how these substances can help individuals cope with existential fears.
Read moreHere’s an informative article on navigating the legal landscape of psychedelics.
Read moreHere’s a great article on the tendency to deny and downplay the harms of psychedelics.
Read moreThis investigation represents the university’s first human trials involving a Schedule I substance, classified by the federal government as having no accepted medical use.
Psilocybin, commonly known as “shrooms” or “magic mushrooms,” can significantly distort users’ sense of time, mood, and reality, often causing hallucinations.
Read moreA recent case study has highlighted the potential of using MDMA and psilocybin to manage these persistent symptoms.
Read moreHere’s a wonderful article on how people with cluster headaches became unexpected psychedelic pioneers.
Read moreA recent study has challenged the prevailing belief that childhood trauma influences the experiences individuals have with ayahuasca, a psychoactive brew traditionally used by Indigenous cultures for spiritual and healing purposes.
Read more